Leila Ryma Lazouni

Mohammed El Amine Lazouni, Leila Ryma Lazouni, Zineb Aziza Elaouaber et al.

In this paper, we present CornOrb, a publicly accessible multimodal dataset of Orbscan corneal topography images and clinical annotations collected from patients in Algeria. The dataset comprises 1,454 eyes from 744 patients, including 889 normal eyes and 565 keratoconus cases. For each eye, four corneal maps are provided (axial curvature, anterior elevation, posterior elevation, and pachymetry), together with structured tabular data including demographic information and key clinical parameters such as astigmatism, maximum keratometry (Kmax), central and thinnest pachymetry, and anterior/posterior asphericity. All data were retrospectively acquired, fully anonymized, and pre-processed into standardized PNG and CSV formats to ensure direct usability for artificial intelligence research. This dataset represents one of the first large-scale Orbscan-based resources from Africa, specifically built to enable robust AI-driven detection and analysis of keratoconus using multimodal data. The data are openly available at Zenodo.

Rachid Zeghlache, Ikram Brahim, Pierre-Henri Conze et al.

The MARIO challenge, held at MICCAI 2024, focused on advancing the automated detection and monitoring of age-related macular degeneration (AMD) through the analysis of optical coherence tomography (OCT) images. Designed to evaluate algorithmic performance in detecting neovascular activity changes within AMD, the challenge incorporated unique multi-modal datasets. The primary dataset, sourced from Brest, France, was used by participating teams to train and test their models. The final ranking was determined based on performance on this dataset. An auxiliary dataset from Algeria was used post-challenge to evaluate population and device shifts from submitted solutions. Two tasks were involved in the MARIO challenge. The first one was the classification of evolution between two consecutive 2D OCT B-scans. The second one was the prediction of future AMD evolution over three months for patients undergoing anti-vascular endothelial growth factor (VEGF) therapy. Thirty-five teams participated, with the top 12 finalists presenting their methods. This paper outlines the challenge's structure, tasks, data characteristics, and winning methodologies, setting a benchmark for AMD monitoring using OCT, infrared imaging, and clinical data (such as the number of visits, age, gender, etc.). The results of this challenge indicate that artificial intelligence (AI) performs as well as a physician in measuring AMD progression (Task 1) but is not yet able of predicting future evolution (Task 2).